Oncotarget

Reviews:

Non-coding RNA: a potential biomarker and therapeutic target for sepsis

Tie-Ning Zhang, Da Li, Jing Xia, Qi-Jun Wu, Ri Wen, Ni Yang and Chun-Feng Liu _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:91765-91778. https://doi.org/10.18632/oncotarget.21766

Metrics: PDF 1364 views  |   HTML 2955 views  |   ?  


Abstract

Tie-Ning Zhang1, Da Li2, Jing Xia1, Qi-Jun Wu3, Ri Wen1, Ni Yang1 and Chun-Feng Liu1

1Department of Pediatrics, PICU, Shengjing Hospital of China Medical University, Shenyang, China

2Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China

3Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, Shenyang, China

Correspondence to:

Chun-Feng Liu, email: zhliu258@hotmail.com

Keywords: sepsis, non-coding RNA, biogenesis, biomarkers, therapeutic target

Received: April 28, 2017    Accepted: September 03, 2017    Published: October 10, 2017

ABSTRACT

Sepsis, a syndrome of physiologic, pathologic, and biochemical abnormalities caused by an altered systemic host response to infection, has become the main cause of death among patients admitted to the intensive care units. Recently, genome-wide expression analysis revealed that over 80% of the essential genetic elements were altered in critically ill patients. Notably, non-coding RNAs, including microRNAs, long non-coding RNAs and circular RNAs, have been proven to play essential roles in innate immunity, mitochondrial dysfunction and organ dysfunction. In this review, we introduced the biogenesis of non-coding RNAs briefly and summed up different kinds of non-coding RNAs in regulation of sepsis, which could provide a more comprehensive understanding about pathogenesis of the disease. Additionally, we summarized the limitations of current biomarkers and then recommended some non-coding RNAs as novel potential biomarkers for sepsis and sepsis-induced organ dysfunction. Besides, we also introduced some problems and challenges that need to be overcome during the clinical application of non-coding RNAs. Future research should focus on elucidating their molecular mechanisms, particularly long non-coding RNAs as well as circular RNAs and sepsis, to further understanding of the disease process. With the in-depth understanding of the mechanism of sepsis, non-coding RNAs provide a new insight into sepsis and could become the novel therapeutic targets in the future.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 21766